Evidence map›Paper›PMID 33313984›Full record

ArticleHealth economics review2020

Application study of the EQ-5D-5L in oncology: linking self-reported quality of life of patients with advanced or metastatic colorectal cancer to clinical data from a German tumor registry.

Kathrin Borchert, Christian Jacob, Natalie Wetzel, Martina Jänicke, Egbert Eggers, Annette Sauer, Norbert Marschner, Julia Altevers, Thomas Mittendorf, Wolfgang Greiner

Open access · goldAbstract read
In one paragraph

Article in Health economics review, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Patient-reported outcome measures in penile cancer: a narrative review.International journal of impotence research · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Quality of life of patients with hematological malignancies and factors affecting health state utility values.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Kathrin BorchertXcenda GmbH, Hannover, Germany. kathrin.borchert@xcenda.de.ORCID https://orcid.org/0000-0003-2769-0075
Christian JacobXcenda GmbH, Hannover, Germany.
Natalie WetzeliOMEDICO AG, Freiburg im Breisgau, Germany.
Martina JänickeiOMEDICO AG, Freiburg im Breisgau, Germany.
Egbert EggersKreiskrankenhaus Torgau, Torgau, Germany.
Annette SauerMedizinisches Versorgungszentrum für Blut- und Krebserkrankungen, Potsdam, Germany.
Norbert MarschnerPraxis für interdisziplinäre Onkologie und Hämatologie, Freiburg im Breisgau, Germany.
Julia AlteversXcenda GmbH, Hannover, Germany.
Thomas MittendorfXcenda GmbH, Hannover, Germany.
Wolfgang GreinerUniversität Bielefeld, Bielefeld, Germany.
Iomedico (Germany) · DEAscendis Pharma (Denmark) · DKBielefeld University · DECenter for HIV and Hepatogastroenterology · DEPraxis für Hämatologie und Onkologie · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe EQ-5D-5L questionnaire is used in oncology to generate health-related quality of life (HRQoL) weights and corresponding health states. The purpose was to explore the relationship between demographic and clinical characteristics and HRQoL among advanced or metastatic colorectal cancer (CRC) patients by linking clinical data of a German CRC registry to self-reported HRQoL measures from the EQ-5D-5L.

methodsThe study sample included patients with advanced or metastatic CRC currently recruited in the German Tumor Registry Colorectal Cancer. The EQ-5D-5L was administered once to patients who were at the start or at later stages of palliative treatment. Data on comorbidities, disease-specific health states, symptoms, and treatment status were drawn from the registry. Multivariate regression analyses were performed to explore the impact of patient and disease characteristics on HRQoL.

resultsIn total, n = 433 questionnaires were included in the data analysis. Mean age of patients was 66.3 years and 61.2% were male. The mean EQ-5D-5L utility score was 0.82 and the mean EQ-5D-5L VAS score was 62.05. The regression analyses revealed that none of the demographic characteristics and few of the clinical characteristics, such as fatigue and pain, had a significant impact on the HRQoL.

conclusionsThe study demonstrated a reduced HRQoL of patients with advanced or metastatic CRC when compared to the general population. The symptoms fatigue and pain negatively affected the HRQoL, whereas other characteristics such as age, gender, and comorbidities did not have a significant impact on HRQoL.

Indexed as

Colorectal cancerData linkageEQ-5D-5LPatient reported outcomesQuality of lifeTumor registry

Identifiers

PMID33313984
PMCPMC7733616
OpenAlexW3110926557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.